Dissolved and financials
CVR: 40357092
DKK -7,007
Gross profit
Net result: DKK -39,300
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Ceased 8 June 2022
CVR · view overview
No headcount reported
Director role ended: Mads Spangaard Rasmussen
CVR · 08/06/2022
View the full event history
AsoGen Therapeutics IVS was a Danish company of the type Iværksætterselskab based in Odense S, founded in 2019. The company has been dissolved on 8 June 2022. The company was registered under the industry Fremstilling af farmaceutiske præparater. In 2020, the company reported a gross profit of DKK -7,007 and a net result of DKK -39,300. Equity in the 2020 report amounted to DKK -55,744.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202001/01/2020 – 31/12/2020 | -7 t. | -39 t. | 238 t. | -56 t. | - |
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreNo. AsoGen Therapeutics IVS is registered in the Danish CVR register with the status Dissolved and ceased on 8 June 2022.
The CVR number of AsoGen Therapeutics IVS is 40357092.
In 2020, AsoGen Therapeutics IVS reported a gross profit of DKK -7,007.
AsoGen Therapeutics IVS was founded on 15 March 2019.
AsoGen Therapeutics IVS was registered under the industry Fremstilling af farmaceutiske præparater (industry code 212000).
AsoGen Therapeutics IVS was located at c/o HM Holding ApS, Sivlandvænget 3 1., 5260 Odense S.
As of June 8, 2022, Mads Spangaard Rasmussen has stepped down as liquidator of AsoGen Therapeutics IVS.
On June 8, 2022, AsoGen Therapeutics IVS exited liquidation.
AsoGen Therapeutics IVS was dissolved on June 8, 2022.
As of October 13, 2021, Markus Sakari Kauppinen has left the board of directors of AsoGen Therapeutics IVS.
As of October 13, 2021, Mads Spangaard Rasmussen is registered as liquidator of AsoGen Therapeutics IVS.
As of October 13, 2021, Mads Spangaard Rasmussen has stepped down as chairman of AsoGen Therapeutics IVS.
As of October 13, 2021, Markus Sakari Kauppinen has stepped down as director of AsoGen Therapeutics IVS.
On October 13, 2021, AsoGen Therapeutics IVS entered liquidation.
AsoGen Therapeutics IVS has published its annual report for 2020. Gross profit came to DKK -7,007, and the net result was DKK -39,300.
AsoGen Therapeutics IVS has published its interim report for the period March 15, 2019 – December 31, 2019.
As of March 15, 2019, Markus Sakari Kauppinen has joined the board of directors of AsoGen Therapeutics IVS.
As of March 15, 2019, Mads Spangaard Rasmussen is registered as chairman of AsoGen Therapeutics IVS.
As of March 15, 2019, Markus Sakari Kauppinen is registered as director of AsoGen Therapeutics IVS.
AsoGen Therapeutics IVS was founded on March 15, 2019.
Companies in the same industry and area
CVR 39724758
CVR 43458078
CVR 39467135
CVR 42499781
